Luminex Corp, Austin, Tex, and Bio-Techne Corp, Minneapolis, have signed a new distribution and supply agreement through 2020. The agreement extends an existing relationship between the two companies for immunoassay development and commercialization of Bio-Techne biological content using the Luminex testing platform. Furthermore, the agreement will permit Bio-Techne to distribute Luminex multiplexing instrumentation, including the Luminex 200, Flexmap 3D, and Magpix systems in major markets worldwide.
Todd Bennett, Luminex.
“We are very pleased to broaden our relationship with Bio-Techne, a leading global player in the research, diagnostics, and clinical controls markets,” says Todd Bennett, vice president of global sales and customer operations at Luminex. “We believe enabling Bio-Techne to develop assay content and distribute Luminex multiplexing instruments will aid our goal of providing laboratories of all sizes access to multiplexing solutions for a range of applications. With its global scope, Bio-Techne is an ideal partner that can ensure our advanced multiplexing solutions reach the right scientists and researchers.”
Gerry Andros, Bio-Techne.
“We have been a partner with Luminex for many years, and given our strong market position in immunoassay applications, it is logical for Bio-Techne to continue to support our customers with complete customized workflow solutions, including instruments,” says Gerry Andros, vice president of sales for Bio-Techne. “This is consistent with the company’s strategic direction of providing full solutions in the life science research space, including both biological content and instruments.”
Financial terms were not disclosed.
Luminex offers three multiplex instruments, enabling laboratories to choose a platform that fits their throughput and flexibility needs. The compact Magpix multiplexing unit performs up to 50 different tests in a single reaction volume and reads a 96-well plate in just 60 minutes. The Luminex 200 system provides laboratorians the ability to perform up to 100 different tests in a single reaction volume while using either magnetic or polystyrene microspheres. The Flexmap 3D platform is capable of simultaneously measuring up to 500 genes or proteins from a small sample. All three instruments run multiplexed assays for both proteins and nucleic acids, whether kit-based or lab-developed.
For more information, visit Luminex and Bio-Techne.
